AbbVie at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

AbbVie brings 3 presentations to SLAS2027 in San Diego. Its program covers plate-based proteomics for targeted protein degradation, an integrated high-throughput chemistry and AI platform for drug discovery, and modular automation for biologic formulation development.

OrganizationSLAS2027 Attendance
AbbVie
North Chicago, IL
Biopharma
Biopharmaceutical company developing medicines in immunology, oncology, neuroscience and eye care.
Talk
Mon Feb 1
3:30–3:55pm
Part of Harnessing Novel E3 Ligase Biology to Broaden the Target Space
Application of Plate-Based Proteomics to Targeted Protein Degradation
Ballroom 6E
New modalities
Talk
Tue Feb 2
10–10:25am
Part of Automation Technology to Maximize Organic Chemistry Synthesis
From Data to Insights: Building an Integrated HT Chemistry and AI/ML Platform for Modern Drug Discovery
Ballroom 6F
Automation and robotics
Poster
Tue Feb 2
2–3pm
Part of Poster Session D
Walk-Up and Plug and Play Modular End-to-End Automation for Agile Biologic Formulation Development
SAILS Pavilion
Automation and robotics

Explore the full SLAS2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full SLAS2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at AbbVie

Tell us what you sell and we’ll find the people at AbbVie most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction